Many breast cancer survivors may be able to forgo mammograms in old age

by Denise MannOlder breast cancer survivors often have other medical issues and a shorter life expectancy than younger breast cancer survivors. What's more, their cancers are often slow-growing, a

Updated on: January 15,2024

Many breast cancer survivors may be able to forgo mammograms in old age

by Denise MannOlder breast cancer survivors often have other medical issues and a shorter life expectancy than younger breast cancer survivors. What's more, their cancers are often slow-growing, a

Updated on:January 15,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on: January 30,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on:January 30,2024

Genome offers clues to esophageal cancer disparity

by University of MichiganEsophagus graphic. Credit: Michigan MedicineA change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this popu

Updated on: March 06,2024

Genome offers clues to esophageal cancer disparity

by University of MichiganEsophagus graphic. Credit: Michigan MedicineA change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this popu

Updated on:March 06,2024

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How

Updated on: January 30,2024

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How

Updated on:January 30,2024

'Fighting' cancer may detract men from palliative care

by University of Rochester Medical CenterMen with advanced cancer are 30 percent less likely than women to consider palliative care, according to a University of Rochester Medical Center study.Re

Updated on: March 01,2024

'Fighting' cancer may detract men from palliative care

by University of Rochester Medical CenterMen with advanced cancer are 30 percent less likely than women to consider palliative care, according to a University of Rochester Medical Center study.Re

Updated on:March 01,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on: January 30,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on:January 30,2024

Researchers identify potential target in myeloid malignancies

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI165510Researchers at Children's Hospital of Philadelp

Updated on: February 18,2024

Researchers identify potential target in myeloid malignancies

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI165510Researchers at Children's Hospital of Philadelp

Updated on:February 18,2024

Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers at UNC Lineberger Comprehensive Cancer Center have found a possible way to overcome barriers that block

Updated on: January 04,2024

Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers at UNC Lineberger Comprehensive Cancer Center have found a possible way to overcome barriers that block

Updated on:January 04,2024

High fail rate for melanoma self-checks increasing cancer risk, new study finds

bySouthern Cross UniversityCredit: ROCKETMANN TEAM from PexelsAustralians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-

Updated on: July 05,2024

High fail rate for melanoma self-checks increasing cancer risk, new study finds

bySouthern Cross UniversityCredit: ROCKETMANN TEAM from PexelsAustralians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-

Updated on:July 05,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on: January 23,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on:January 23,2024

Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has

Updated on: March 08,2024

Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has

Updated on:March 08,2024

A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

by The University of Hong KongGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111821A research team from LKS Faculty of Medicine, the University of Hong Kong

Updated on: January 30,2024

A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

by The University of Hong KongGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111821A research team from LKS Faculty of Medicine, the University of Hong Kong

Updated on:January 30,2024